J. Lai

发表

BreakID: genomics breakpoints identification to detect gene fusion events using discordant pairs and split reads

Yang Zhang, Ying Fu, Linfang Jin, 2019, Bioinform..

Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.

J. Lai, Cheng Huang, Z. Song, 2020, The oncologist.

Local Irradiation Sensitized Tumors to Adoptive T Cell Therapy via Enhancing the Cross-Priming, Homing, and Cytotoxicity of Antigen-Specific CD8 T Cells

J. Lai, Ling Chen, Qiuyu Zhang, 2019, Front. Immunol..

M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma

J. Lai, Han Lin, Wenfang Cheng, 2022, BMC Cancer.

Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway.

J. Lai, Xiandong Lin, Shuiliang Wang, 2019, Life sciences.

Gemcitabine and checkpoint blockade exhibit synergistic anti-tumor effects in a model of murine lung carcinoma.

J. Lai, Yao Wang, Bin Du, 2020, International immunopharmacology.

Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice

M. Biel, J. Lai, Jizhen Lin, 2014, International journal of oncology.

Cetuximab Maintenance Therapy in Patients with Unresectable Wild-Type RAS and BRAF Metastatic Colorectal Cancer: A Single-Institute Prospective Study

J. Lai, Xinli Wang, Xiaoyan Lin, 2020, Advances in Therapy.

Next-generation sequencing of circulating tumor DNA for detection of gene mutations in lung cancer: implications for precision treatment

J. Lai, Ri-ping Wu, Zongyang Yu, 2018, OncoTargets and therapy.

Clinical outcomes and toxicities of locally advanced esophageal squamous cell carcinoma patients treated with early thoracic radiation therapy after induction chemotherapy

Yi Yu, J. Lai, Han Lin, 2023, International Journal of Clinical Oncology.

MET gene fusions in non-small cell lung cancer (NSCLC) in the Chinese population: A multicenter study.

J. Lai, Gang Chen, Zhenghua Zhang, 2018 .

The combination of EGFR-TKIs and anlotinib as a first-line therapy for EGFR-mutant advanced non-small cell lung cancer: A multicenter, single-arm, phase II clinical trial.

J. Lai, Tianwen Xu, Zhiyong He, 2021 .

Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity

Y. Liu, J. Lai, Ling Chen, 2021, Frontiers in Oncology.

The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma

J. Lai, Yahua Wu, M. Lin, 2023, Scientific reports.

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study

J. Lai, Yan-qin Lan, Yahua Wu, 2023, Annals of medicine.

Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors

J. Lai, Xue Wu, Q. Ou, 2022, Frontiers in Oncology.